Overweight and obesity. Overweight and obesity
Conditions
Interventions
Intervention 1: First intervention group: Exercising 3 days a week, performing intermittent aerobic activities with high intensity 85-95% of Heart Rate Maximum (HRMax), equivalent to RPE 7-9 on the Bo
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Adults between the ages of 18 to 50 BMI between 25 to 35 No participation in a weight loss program in the past year Lack of regular participation in physical activity in the last 6 months (via SF-IPAQ questionnaire) Absence of pregnancy and breastfeeding Not taking drugs affecting metabolism Absence of musculoskeletal diseases that result in limitations of performing workouts Absence of cardiovascular, respiratory, neurological, psychiatric (via HADS questionnaire), endocrine diseases Being affected by any other weight loss intervention (including receiving nutritional or exercise regimens further than the assigned treatment, receiving supplements and drugs that affect metabolism, using other alternative methods) during the study will lead to exclusion from the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight. Timepoint: The start of the study (before the intervention) and the 12th week. Method of measurement: Using the same standard method and scale.;Maximal O2 uptake. Timepoint: The start of the study (before the intervention) and the 12th we. Method of measurement: The step test will be performed using the Queen's college method, and the maximal O2 uptake will be estimated via the formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adherence rate. Timepoint: Weeks 4,8 and 12. Method of measurement: The percentage of the number of training sessions that have been performed completely to the total sessions.;Drop out rate. Timepoint: Weeks 4,8 and 12. Method of measurement: The number of people who dropped out during the study.;Adverse events. Timepoint: Weeks 4,8 and 12. Method of measurement: Any complication related to the intervention that occur during the study is recorded in the exercise log book.;Anthropometric findings(waist circumference, hip circumference, waist/hip circumference ratio). Timepoint: At the start of the study (before the intervention) and the 12th week. Method of measurement: Using the same standard method and metric tool.;Blood pressure. Timepoint: At the start of the study (before the intervention) and the 12th week. Method of measurement: In a sitting position and after 5 minutes of rest, with the same sphygmomanometer, the average of two measurements will be recorded. If there is a difference of more than 5mmHg in the measurements, whether systolic or diastolic pressure, the measurement will be repeated for the third time. .;Lipid profile including TG, LDL and HDL. Timepoint: At the start of the study (before the intervention) and the 12th week. Method of measurement: Examined at the same laboratory for biochemical evaluations after 12hours of fasting.;Factors related to glucose metabolism including FBS and HOMA-IR. Timepoint: At the start of the study (before the intervention) and the 12th week. Method of measurement: Examined at the same laboratory for biochemical evaluations after 12hours of fasting.;Body composition (body fat percentage). Timepoint: At the start of the study (before the intervention) and the 12th week. Method of measurement: The percentage of body fat and other components will be determined by the Bioelectrical Impedance Analysis method using the relevant device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedayin Hosseini
Tehran University of Medical Sciences
Outcome results
None listed